Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 485

1.

Molecular regulation of androgen action in prostate cancer.

Dehm SM, Tindall DJ.

J Cell Biochem. 2006 Oct 1;99(2):333-44. Review.

PMID:
16518832
2.

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

Agoulnik IU, Weigel NL.

J Cell Biochem. 2006 Oct 1;99(2):362-72. Review.

PMID:
16619264
3.

Androgen receptor and prostate cancer: molecular aspects and gene expression profiling.

Sommer A, Haendler B.

Curr Opin Drug Discov Devel. 2003 Sep;6(5):702-11. Review.

PMID:
14579520
4.

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G.

Cancer Res. 2006 May 15;66(10):5012-20.

5.

Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.

Takayama K, Tsutsumi S, Suzuki T, Horie-Inoue K, Ikeda K, Kaneshiro K, Fujimura T, Kumagai J, Urano T, Sakaki Y, Shirahige K, Sasano H, Takahashi S, Kitamura T, Ouchi Y, Aburatani H, Inoue S.

Cancer Res. 2009 Jan 1;69(1):137-42. doi: 10.1158/0008-5472.CAN-08-3633.

6.

Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.

Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE 3rd, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL.

Cancer Res. 2006 Nov 1;66(21):10594-602.

7.

Androgen axis in prostate cancer.

Culig Z, Bartsch G.

J Cell Biochem. 2006 Oct 1;99(2):373-81. Review.

PMID:
16598769
8.

Androgen receptor signaling in androgen-refractory prostate cancer.

Grossmann ME, Huang H, Tindall DJ.

J Natl Cancer Inst. 2001 Nov 21;93(22):1687-97. Review.

PMID:
11717329
10.

Collocation of androgen receptor gene mutations in prostate cancer.

Buchanan G, Greenberg NM, Scher HI, Harris JM, Marshall VR, Tilley WD.

Clin Cancer Res. 2001 May;7(5):1273-81.

12.

Androgen regulation of gene expression.

Lamont KR, Tindall DJ.

Adv Cancer Res. 2010;107:137-62. doi: 10.1016/S0065-230X(10)07005-3. Review.

PMID:
20399963
13.

Androgen receptor involvement in the progression of prostate cancer.

Suzuki H, Ueda T, Ichikawa T, Ito H.

Endocr Relat Cancer. 2003 Jun;10(2):209-16. Review.

14.

Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.

D'Antonio JM, Ma C, Monzon FA, Pflug BR.

Prostate. 2008 May 15;68(7):698-714. doi: 10.1002/pros.20677.

PMID:
18302219
15.

Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling.

Mink SR, Hodge A, Agus DB, Jain A, Gross ME.

Prostate. 2010 Aug;70(11):1201-10. doi: 10.1002/pros.21155.

PMID:
20564426
16.

Mechanisms of prostate cancer cell survival after inhibition of AR expression.

Cohen MB, Rokhlin OW.

J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022. Review.

PMID:
19115258
17.
18.

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.

Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

PMID:
18163430
19.

Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.

Marrocco DL, Tilley WD, Bianco-Miotto T, Evdokiou A, Scher HI, Rifkind RA, Marks PA, Richon VM, Butler LM.

Mol Cancer Ther. 2007 Jan;6(1):51-60. Epub 2007 Jan 11.

20.

The role of the androgen receptor in prostate cancer.

Huang H, Tindall DJ.

Crit Rev Eukaryot Gene Expr. 2002;12(3):193-207. Review.

PMID:
12449343

Supplemental Content

Support Center